A Clinical Update on Employing Tocilizumab to Fight COVID-19
SARS-CoV-2 infection or COVID-19, currently regarded as ‘terror’ worldwide, has spread uncontrollably as a serious menace. Till date, limited effective medicines or treatments are available. The mortality and morbidity rates have increased considerably, which have been aggravated by acute respirator...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/78556 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: A Clinical Update on Employing Tocilizumab to Fight COVID-19
- Tocilizumab for the Treatment of AA Amyloidosis
- The Role of Tocilizumab in the Treatment of Rheumatoid Arthritis
- Neumonía por COVID-19 y uso de tocilizumab
- Myths: Barriers to Fighting the COVID-19 Pandemic
- Fighting COVID-19: The Medical Laboratory Involvement
- Role of Graphene and Graphene Derived Materials to Fight with COVID-19